Search Results
Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China
Key Laboratory for Atherosclerology of Hunan Province, Department of Nutrition and Metabolism, Clinical Research Center for Diabetes, Institute of Cardiovascular Research, Life Science Research Center, University of South China, Hengyang, Hunan 421001, People's Republic of China
Search for other papers by Qinkai Li in
Google Scholar
PubMed
Search for other papers by Weidong Yin in
Google Scholar
PubMed
Search for other papers by Manbo Cai in
Google Scholar
PubMed
Search for other papers by Yi Liu in
Google Scholar
PubMed
Search for other papers by Hongjie Hou in
Google Scholar
PubMed
Search for other papers by Qingyun Shen in
Google Scholar
PubMed
Search for other papers by Chi Zhang in
Google Scholar
PubMed
Search for other papers by Junxia Xiao in
Google Scholar
PubMed
Search for other papers by Xiaobo Hu in
Google Scholar
PubMed
Search for other papers by Qishisan Wu in
Google Scholar
PubMed
Search for other papers by Makoto Funaki in
Google Scholar
PubMed
Search for other papers by Yutaka Nakaya in
Google Scholar
PubMed
Introduction The metabolic syndrome (syndrome X) refers to the aggregation of a cluster of risk factors, including insulin resistance/hyperinsulinemia and dyslipidemia (increased low-density lipoprotein cholesterol (LDL-C), and depressed high
Department of Medicine, Monash University, Clayton, Victoria, Australia
Search for other papers by Jun Yang in
Google Scholar
PubMed
Search for other papers by Morag J Young in
Google Scholar
PubMed
Search for other papers by Timothy J Cole in
Google Scholar
PubMed
Search for other papers by Peter J Fuller in
Google Scholar
PubMed
.33, 95% CI 1.01–1.74) and metabolic syndrome (OR 1.53, 1.22–1.91) in subjects with PA compared to those with essential hypertension ( Monticone et al. 2018 ). Consistent with this, treatment of PA has been shown to increase insulin secretion and
Search for other papers by Mohamed Asrih in
Google Scholar
PubMed
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
, insulin resistance, hypertension, and dyslipidemia, suggesting that NAFLD might be considered as the liver manifestation of the metabolic syndrome ( Marchesini et al . 2001 , Adams et al . 2005 ). The metabolic syndrome is a leading cause of mortality
Search for other papers by Paolo Comeglio in
Google Scholar
PubMed
Search for other papers by Ilaria Cellai in
Google Scholar
PubMed
Search for other papers by Tommaso Mello in
Google Scholar
PubMed
Search for other papers by Sandra Filippi in
Google Scholar
PubMed
Search for other papers by Elena Maneschi in
Google Scholar
PubMed
Search for other papers by Francesca Corcetto in
Google Scholar
PubMed
Search for other papers by Chiara Corno in
Google Scholar
PubMed
Search for other papers by Erica Sarchielli in
Google Scholar
PubMed
Search for other papers by Annamaria Morelli in
Google Scholar
PubMed
Search for other papers by Elena Rapizzi in
Google Scholar
PubMed
Search for other papers by Daniele Bani in
Google Scholar
PubMed
Search for other papers by Daniele Guasti in
Google Scholar
PubMed
Search for other papers by Gabriella Barbara Vannelli in
Google Scholar
PubMed
Search for other papers by Andrea Galli in
Google Scholar
PubMed
Search for other papers by Luciano Adorini in
Google Scholar
PubMed
I.N.B.B. – Istituto Nazionale Biostrutture e Biosistemi, Rome, Italy
Search for other papers by Mario Maggi in
Google Scholar
PubMed
I.N.B.B. – Istituto Nazionale Biostrutture e Biosistemi, Rome, Italy
Gynecologic Endocrinology Research Unit, Department of Experimental and Clinical Biomedical Sciences ‘Mario Serio’, University of Florence, Florence, Italy
Search for other papers by Linda Vignozzi in
Google Scholar
PubMed
Introduction Metabolic syndrome (MetS) is associated with a wide range of cardiometabolic risk conditions, including coronary heart disease, type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD) ( Corona et al. 2007 ). Among
Search for other papers by Kirsty A Walters in
Google Scholar
PubMed
Australian Institute of Musculoskeletal Science, Victoria University, St. Albans, Victoria, Australia
Search for other papers by Alba Moreno-Asso in
Google Scholar
PubMed
Australian Institute of Musculoskeletal Science, Victoria University, St. Albans, Victoria, Australia
Monash Centre for Health Research and Implementation, Monash University and Monash Health, Clayton, Victoria, Australia
Medicine at Western Health, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia
Search for other papers by Nigel K Stepto in
Google Scholar
PubMed
Search for other papers by Michael W Pankhurst in
Google Scholar
PubMed
Search for other papers by Valentina Rodriguez Paris in
Google Scholar
PubMed
Search for other papers by Raymond J Rodgers in
Google Scholar
PubMed
Introduction Polycystic ovary syndrome (PCOS) is the most common endocrine condition affecting females of reproductive age, with women suffering from a wide range of ill-health symptoms including endocrine, reproductive, metabolic and
Search for other papers by Gisela Helfer in
Google Scholar
PubMed
Search for other papers by Qing-Feng Wu in
Google Scholar
PubMed
Introduction Adipokines, secreted by adipose tissue, are involved in the pathogenesis of metabolic syndrome ( Lehr et al . 2012 ). Chemerin, encoded by the gene retinoic acid receptor responder 2 ( Rarres2 ), also known as tazarotene
Search for other papers by Siân E Piret in
Google Scholar
PubMed
Search for other papers by Rajesh V Thakker in
Google Scholar
PubMed
for generating mouse models of human diseases have greatly facilitated studies of complex inherited endocrine and metabolic syndromes that have investigated mechanisms and treatments, which would not be easily feasible in man. In addition, the
Search for other papers by Philip Newsholme in
Google Scholar
PubMed
Search for other papers by Vinicius Cruzat in
Google Scholar
PubMed
Search for other papers by Frank Arfuso in
Google Scholar
PubMed
Search for other papers by Kevin Keane in
Google Scholar
PubMed
manifestations of the metabolic syndrome. Glucose, the body's primary metabolic fuel source, is ingested usually in polymeric form following the consumption of a mixed meal, and the subsequent postprandial elevation in blood glucose level is stringently modulated
Department of Experimental Physiology, Department of Internal Medicine III and Institute of Physiology, Department of Biological Chemistry, Endocrine Unit, Experimental Research Centre, University of Athens Medical School, Athens, Greece
Search for other papers by Antonios Chatzigeorgiou in
Google Scholar
PubMed
Department of Experimental Physiology, Department of Internal Medicine III and Institute of Physiology, Department of Biological Chemistry, Endocrine Unit, Experimental Research Centre, University of Athens Medical School, Athens, Greece
Search for other papers by Eleni Kandaraki in
Google Scholar
PubMed
Search for other papers by Christina Piperi in
Google Scholar
PubMed
Search for other papers by Sarantis Livadas in
Google Scholar
PubMed
Search for other papers by Athanasios G Papavassiliou in
Google Scholar
PubMed
Search for other papers by Michael Koutsilieris in
Google Scholar
PubMed
Search for other papers by Apostolos Papalois in
Google Scholar
PubMed
Search for other papers by Evanthia Diamanti-Kandarakis in
Google Scholar
PubMed
pathogenesis of other diseases such as atherosclerosis, chronic renal failure, polycystic ovary syndrome (PCOS) and Alzheimer's disease ( Mukhopadhyay & Mukherjee 2005 , Tan et al . 2011 ). Furthermore, data obtained from humans and experimental animals
Search for other papers by Rubén Marín-Juez in
Google Scholar
PubMed
Search for other papers by Susanne Jong-Raadsen in
Google Scholar
PubMed
Search for other papers by Shuxin Yang in
Google Scholar
PubMed
Search for other papers by Herman P Spaink in
Google Scholar
PubMed
Introduction Metabolic disorders (e.g. diabetes, obesity, and metabolic syndrome) have over the past three decades reached pandemic dimensions, affecting a large number of the world population ( Wild & Byrne 2006 , Lin & Sun 2010 ). Insulin